Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 277

1.

The role of corticotropin-releasing factor in depression and anxiety disorders.

Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB.

J Endocrinol. 1999 Jan;160(1):1-12. Review.

2.
5.

Non-peptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders.

Kehne J, De Lombaert S.

Curr Drug Targets CNS Neurol Disord. 2002 Oct;1(5):467-93. Review.

PMID:
12769601
7.

The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal.

Skelton KH, Gutman DA, Thrivikraman KV, Nemeroff CB, Owens MJ.

Psychopharmacology (Berl). 2007 Jun;192(3):385-96. Epub 2007 Feb 13.

PMID:
17297634
8.
9.

Stress responsive neurohormones in depression and anxiety.

Ströhle A, Holsboer F.

Pharmacopsychiatry. 2003 Nov;36 Suppl 3:S207-14. Review.

PMID:
14677081
10.

Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders.

Ressler KJ, Nemeroff CB.

Depress Anxiety. 2000;12 Suppl 1:2-19. Review.

PMID:
11098410
11.

Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior.

Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW.

J Neurosci. 1994 May;14(5 Pt 1):2579-84.

12.

Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: behavioral, endocrine and neurochemical effects in the rat.

Arborelius L, Skelton KH, Thrivikraman KV, Plotsky PM, Schulz DW, Owens MJ.

J Pharmacol Exp Ther. 2000 Aug;294(2):588-97.

13.

[The neuroendocrinology of stress and the pathophysiology and therapy of depression and anxiety].

Ströhle A.

Nervenarzt. 2003 Mar;74(3):279-91; quiz 292. German.

PMID:
12627245
14.

Do anxiety and depression have a common pathophysiological mechanism?

Boyer P.

Acta Psychiatr Scand Suppl. 2000;(406):24-9. Review.

PMID:
11131467
15.
16.

The CRF1 receptor, a novel target for the treatment of depression, anxiety, and stress-related disorders.

Kehne JH.

CNS Neurol Disord Drug Targets. 2007 Jun;6(3):163-82. Review.

PMID:
17511614
17.
18.

The role of corticotropin-releasing factor in the anxiogenic effects of ethanol withdrawal.

Menzaghi F, Rassnick S, Heinrichs S, Baldwin H, Pich EM, Weiss F, Koob GF.

Ann N Y Acad Sci. 1994 Oct 31;739:176-84. Review.

PMID:
7832471
19.

Differential neuroendocrine responses to chronic variable stress in adult Long Evans rats exposed to handling-maternal separation as neonates.

Ladd CO, Thrivikraman KV, Huot RL, Plotsky PM.

Psychoneuroendocrinology. 2005 Jul;30(6):520-33.

PMID:
15808921
20.

Recent advances in the neurobiology of anxiety disorders: implications for novel therapeutics.

Mathew SJ, Price RB, Charney DS.

Am J Med Genet C Semin Med Genet. 2008 May 15;148C(2):89-98. doi: 10.1002/ajmg.c.30172. Review.

PMID:
18412102

Supplemental Content

Support Center